XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 10, 2021
shares
Nov. 30, 2021
USD ($)
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
Jun. 15, 2022
shares
Mar. 31, 2022
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Shares reserved for future issuance | shares     151,345,269   151,345,269     144,601,515
Granted | shares         3,670,200      
Shares Available for Grant, Exercised | shares         2,496,363      
Weighted-average grant date fair values of options granted | $ / shares         $ 2.54      
Intrinsic value of vested options exercised         $ 4,100      
Unrecognized stock-based compensation cost     $ 83,700   $ 83,700      
Weighted average period over which unrecognized compensation is expected to be recognized         2 years 8 months 12 days      
Proceeds from exercise of stock options         $ 3,944 $ 5,624    
Lemonaid Health, Inc. [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Vesting period   4 years            
Unrecognized stock-based compensation cost     33,900   33,900      
Weighted average period over which unrecognized compensation is expected to be recognized   3 years 1 month 6 days            
Common stock granted subject to vest | shares   3,747,027            
Common stock granted subject to vest, Weighted average grant date fair value   $ 43,900            
Secondary Sale Transaction [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Stock-based compensation expense     28,967 $ 10,427 59,430 20,064    
General and Administrative Expense [Member] | Lemonaid Health, Inc. [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Stock-based compensation expense     2,800   5,500      
General and Administrative Expense [Member] | Secondary Sale Transaction [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Stock-based compensation expense     12,548 $ 3,172 24,719 5,501    
Stock Option Activity [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Tax benefit recognized from stock option exercises         0 $ 0    
Restricted Stock Units [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Unrecognized stock-based compensation cost     $ 126,700   $ 126,700      
Weighted average period over which unrecognized compensation is expected to be recognized         3 years 2 months 12 days      
2021 Incentive Equity Plan [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Exchange ratio of common stock         2.293698169      
Shares Available for Grant, Beginning balance | shares     22,839,019   22,839,019      
Common stock issued and outstanding, percentage         3.00%      
Exercise price of stock options as a percentage of fair value of shares         110.00%      
Share-based payment award, description         The number of shares of Class A common stock reserved for issuance under the 2021 Plan will automatically increase on January 1 of each calendar year, starting in 2022, in an amount equal to (i) 22,839,019 shares of Class A common stock, (ii) 3.0% of the aggregate number of shares of Class A common stock and Class B common stock outstanding, or (iii) a lesser number of shares determined by the Company’s Board of Directors prior to the applicable January 1 (the “Evergreen Provision”).      
Share-based payment award, expiration period         10 years      
Share-based compensation terms of award         Options under the 2021 Plan have a contractual life of up to ten years. The exercise price of a stock option shall not be less than 100% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors.      
2021 Incentive Equity Plan [Member] | Stock Option Activity [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Percentage of total stock holding     10.00%   10.00%      
2021 Incentive Equity Plan [Member] | Minimum [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Exercise price of stock options as a percentage of fair value of shares         100.00%      
ESPP [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common stock issued and outstanding, percentage (1.00%)              
Potential annual increase in shares reserved for future issuance | shares 5,000,000              
2022 AIP [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Stock-based compensation expense     $ 4,800   $ 9,700      
Other current liabilities     $ 9,700   $ 9,700      
Class A Common Stock [Member] | 2021 Incentive Equity Plan [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Shares reserved for future issuance | shares 136,000,000           13,384,415  
Class A Common Stock [Member] | 2021 Incentive Equity Plan [Member] | Lemonaid Health, Inc. [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Shares reserved for future issuance | shares   2,990,386            
Class A Common Stock [Member] | ESPP [Member]                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Shares reserved for future issuance | shares 11,420,000   10,289,663   10,289,663      
Number of shares issued | shares         1,130,337